Vanguard Group’s The Oncology Institute TOI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$16.9M Buy
4,748,635
+203,390
+4% +$754K ﹤0.01% 2695
2025
Q3
$15.9M Buy
4,545,245
+264,358
+6% +$906K ﹤0.01% 2738
2025
Q2
$8.78M Buy
4,280,887
+2,530,173
+145% +$6.33M ﹤0.01% 2974
2025
Q1
$2M Sell
1,750,714
-3,672
-0.2% -$2.84K ﹤0.01% 3490
2024
Q4
$542K Sell
1,754,386
-29,068
-2% -$7.54K ﹤0.01% 3926
2024
Q3
$583K Hold
1,783,454
﹤0.01% 3931
2024
Q2
$820K Hold
1,783,454
﹤0.01% 3856
2024
Q1
$2.82M Buy
1,783,454
+6,061
+0.3% +$11.5K ﹤0.01% 3485
2023
Q4
$3.63M Buy
1,777,393
+19,359
+1% +$33.6K ﹤0.01% 3402
2023
Q3
$2.46M Sell
1,758,034
-4,916
-0.3% -$5.09K ﹤0.01% 3514
2023
Q2
$970K Sell
1,762,950
-180,593
-9% -$95.6K ﹤0.01% 3909
2023
Q1
$1.32M Buy
1,943,543
+10,937
+0.6% +$14K ﹤0.01% 3829
2022
Q4
$3.19M Buy
1,932,606
+72,364
+4% +$203K ﹤0.01% 3492
2022
Q3
$8.61M Buy
1,860,242
+284,807
+18% +$1.67M ﹤0.01% 3026
2022
Q2
$7.97M Buy
1,575,435
+737,114
+88% +$5.37M ﹤0.01% 3111
2022
Q1
$5.98M Buy
838,321
+395,977
+90% +$2.67M ﹤0.01% 3445
2021
Q4
$4.31M Buy
+442,344
New +$3.93M ﹤0.01% 3692

Other funds holding TOI